Cite
Insulin and liraglutide attenuate brain pathology in diabetic mice by enhancing the Wnt/β-catenin signaling pathway.
MLA
Zhao, Yuan, et al. “Insulin and Liraglutide Attenuate Brain Pathology in Diabetic Mice by Enhancing the Wnt/β-Catenin Signaling Pathway.” Experimental & Therapeutic Medicine, vol. 24, no. 1, July 2022, p. N.PAG. EBSCOhost, https://doi.org/10.3892/etm.2022.11366.
APA
Zhao, Y., Yu, J., Ping, F., Xu, L., Li, W., Zhang, H., & Li, Y. (2022). Insulin and liraglutide attenuate brain pathology in diabetic mice by enhancing the Wnt/β-catenin signaling pathway. Experimental & Therapeutic Medicine, 24(1), N.PAG. https://doi.org/10.3892/etm.2022.11366
Chicago
Zhao, Yuan, Jie Yu, Fan Ping, Lingling Xu, Wei Li, Huabing Zhang, and Yuxiu Li. 2022. “Insulin and Liraglutide Attenuate Brain Pathology in Diabetic Mice by Enhancing the Wnt/β-Catenin Signaling Pathway.” Experimental & Therapeutic Medicine 24 (1): N.PAG. doi:10.3892/etm.2022.11366.